Recursion Pharmaceuticals, Inc. is rated a Sell due to cash burn, Q3 net loss of $162.25M and operational trends. Learn more ...
Different teams need to make the same conclusion multiple times before a consensus is reached and the finding can be built ...
Journalist Karen Hao unpacks the rise of AI “empires,” their ideological roots, and the hidden environmental and societal costs of OpenAI’s quest for artificial general intelligence.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback